abs369.txt	background	&	aims		barrett's	esophagus	(be)	recurs	in	25%	or	more	of	patientstreated	successfully	with	radiofrequency	ablation	(rfa)		so	surveillanceendoscopy	is	recommended	after	complete	eradication	of	intestinal	metaplasia(ceim)		the	frequency	of	surveillance	is	informed	only	by	expert	opinion		weaimed	to	model	the	incidence	of	neoplastic	recurrence		validate	the	model	in	anindependent	cohort		and	propose	evidence-based	surveillance	intervals	methods		we	collected	data	from	the	united	states	radiofrequency	ablationregistry	(us	rfa		2004-2013)	and	the	united	kingdom	national	halo	registry	(uknhr		2007-2015)	to	build	and	validate	models	to	predict	the	incidence	ofneoplasia	recurrence	after	initially	successful	rfa		we	developed	3	categories	ofrisk	and	modeled	intervals	to	yield	0	1%	risk	of	recurrence	with	invasiveadenocarcinoma		we	fit	cox	proportional	hazards	models	assessing	discriminationby	c	statistic	and	95%	confidence	limits	results		the	incidence	of	neoplastic	recurrence	was	associated	with	most	severehistologic	grade	before	ceim		age		endoscopic	mucosal	resection		sex		andbaseline	be	segment	length		in	multivariate	analysis		a	model	based	solely	onmost	severe	pre-ceim	histology	predicted	neoplastic	recurrence	with	a	c	statisticof	0	892	(95%	confidence	limit		0	863-0	921)	in	the	us	rfa	registry		this	modelalso	performed	well	when	we	used	data	from	the	uk	nhr		our	model	divided	patientsinto	3	risk	groups	based	on	baseline	histologic	grade		non-dysplastic	be	indefinite	for	dysplasia		low-grade	dysplasia		and	high-grade	dysplasia		orintramucosal	adenocarcinoma		for	patients	with	low-grade	dysplasia		we	proposesurveillance	endoscopy	at	1	and	3	years	after	ceim		for	patients	with	high-gradedysplasia	or	intramucosal	adenocarcinoma		we	propose	surveillance	endoscopy	at0	25		0	5		and	1	year	after	ceim		then	annually	conclusion		in	analyses	of	data	from	the	us	rfa	and	uk	nhr	for	be		amuch-attenuated	schedule	of	surveillance	endoscopy	would	provide	protection	frominvasive	adenocarcinoma		adherence	to	the	recommended	surveillance	intervalscould	decrease	the	number	of	endoscopies	performed	yet	identify	unresectablecancers	at	rates	less	than	1/1000	endoscopies	
